AI Companies Are Rushing Into Healthcare Like Never Before

Look, I've been covering AI tools for a while now, and I've never seen companies move this fast into a single sector. Healthcare AI is having its moment, and the numbers are honestly wild.
Just this past week alone, we saw OpenAI snap up a health startup called Torch. Then Anthropic rolled out a healthcare version of Claude. And get this - MergeLabs, which Sam Altman is backing, just raised $250 million at an $850 million valuation. For a seed round. That's not normal money, even in 2026's inflated market.
But here's what's got me thinking. Healthcare isn't like other AI applications where a hallucination means you get a wonky image or weird text. When AI gives bad medical advice, people could actually get hurt. I've tested some of these health chatbots myself, and while they're impressive at understanding symptoms, I've also seen them confidently suggest treatments that made me go "wait, what?"
The voice AI angle is particularly interesting. Imagine describing your symptoms to an AI that sounds like a caring doctor, complete with the right tone and bedside manner. It's compelling stuff. But it also makes incorrect information feel more trustworthy, which is exactly the problem regulators are starting to worry about.
What strikes me most is the speed. We're watching billions flow into health AI while the rules are still being written. Smart money says this gold rush will produce some genuinely useful tools. But I can't shake the feeling we're building the plane while flying it, and in healthcare, that's a risky game to play.
Ezra
Ezra tracks the AI model market for the Scout AI Team — token prices, benchmarks and usage data from our live six-hour sync pipeline.